FIELD: medicine.
SUBSTANCE: formation of a risk group of neoplastic disorders in a cervical epithelium is carried out by IF staining of a cervical epithelium smear with using a monoclonal antibody reacting with a sialylated conformational glycopeptide antigen determinant as a part of MUC1 followed by with cell finish staining with chromogenic nuclear stain. The sample is examined by alternated fluorescent light and transmission light. Each cell with a depolarised stained surface membrane detected by fluorescent light is examined in transmission light. If the cells with the depolarised stained surface membrane detected by fluorescent light show cytological symptoms of dyscariosis, and/or proliferative parabasal cell complexes with no symptoms of dyscariosis show depolarised stained surface membranes or granular stained cytoplasm, a patient is subsumed to the risk group of the presence of neoplastic disorders in the cervical epithelium.
EFFECT: higher analysis accuracy.
5 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING PRE-CANCER DISEASES OF UTERINE CERVIX IN WOMEN WITH PAPILLOMA-VIRAL INFECTION | 2006 |
|
RU2310197C1 |
CHLAMYDIA DIAGNOSIS METHOD | 2017 |
|
RU2662940C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR CERVICAL DYSPLASIA AND CERVICAL CANCER | 2012 |
|
RU2538618C2 |
METHOD OF CHOOSING TACTICS OF MANAGING PATIENTS WITH CERVICAL NEOPLASIA | 2011 |
|
RU2472424C1 |
METHOD OF TREATING BACKGROUND AND PRECANCEROUS CERVICAL DISEASES | 2023 |
|
RU2813949C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF CERVICAL INTRAEPITHELIAL NEOPLASIA OF III DEGREE AND PRE-INVASIVE CERVICAL CANCER, ASSOCIATED WITH HUMAN PAPILLOMA VIRUS | 2012 |
|
RU2506892C1 |
METHOD FOR EARLY DIAGNOSTICS OF CERVICAL INTRAEPITHELIAL NEOPLASIAS (CIN) BASED ON METABOLIC MARKERS STUDY | 2016 |
|
RU2629632C1 |
METHOD FOR ASSESSING CONDITIONS OF PROLIFERATIVE CERVICAL DISEASES | 2012 |
|
RU2503960C1 |
METHOD FOR ASSESSING THE RISK OF PROGRESSION OF INTRAEPITHELIAL CERVICAL NEOPLASIA AND DEVELOPMENT OF CERVICAL CANCER BY DETERMINING THE LEVELS OF HUMAN MRNA GENES | 2015 |
|
RU2660360C2 |
METHOD FOR DIFFERENTIATING CERVICAL NEOPLASIA BY LIPID COMPOSITION OF TISSUE | 2019 |
|
RU2737220C1 |
Authors
Dates
2011-12-20—Published
2010-05-27—Filed